CCCC
C4 Therapeutics, Inc.NASDAQHealthcare$2.82+4.44%ClosedMarket Cap: $233.6M
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
2
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Apr 03 | Anderson Kenneth Carl | director | Sell | 4,259 | $2.70 | 68,230 |
| Fri Apr 03 | GROGAN DONNA ROY | director | Sell | 5,370 | $2.70 | 71,512 |
| Wed Feb 18 | Boyle Scott N | officer: Chief Business Officer | Sell | 1,735 | $1.89 | 306,070 |
| Wed Feb 18 | Boyle Scott N | officer: Chief Business Officer | Sell | 20,950 | $0.00 | 306,070 |
| Wed Feb 18 | Boyle Scott N | officer: Chief Business Officer | Sell | 7,269 | $1.89 | 298,801 |
| Wed Feb 18 | Mahaney Paige | officer: Chief Scientific Officer | Sell | 7,050 | $0.00 | 339,356 |
| Wed Feb 18 | Boyle Scott N | officer: Chief Business Officer | Sell | 200,000 | $0.00 | 307,805 |
| Wed Feb 18 | Mahaney Paige | officer: Chief Scientific Officer | Sell | 2,446 | $1.89 | 336,910 |
| Wed Feb 18 | Schick Kelly | officer: Chief People Officer | Sell | 200,000 | $0.00 | 308,885 |
| Wed Feb 18 | Schick Kelly | officer: Chief People Officer | Sell | 5,000 | $0.00 | 308,885 |
| Wed Feb 18 | Mahaney Paige | officer: Chief Scientific Officer | Sell | 240,000 | $0.00 | 339,356 |
| Wed Feb 18 | Boyle Scott N | officer: Chief Business Officer | Sell | 5,000 | $0.00 | 307,805 |